Medicus International: experts in global strategy and communications
Medicus International has been successfully developing global communications for 30 years.
Medicus International has been successfully delivering global communications for 30 years. Our philosophy is to develop inspired strategic solutions through an understanding of market opportunity and trends, product differentiation and required target audience reach. This has established us as experts in defining global communications strategies that deliver brand success.
We believe that we have pioneered the first truly successful approach to delivering marketing solutions to international pharmaceutical clients. With dedicated client service teams based in London and New York, we have extensive experience in supporting pre-launch, launch and post-launch phases in all major therapy areas. These encompass allergy, CV disease, CNS disease (including schizophrenia and depression), diabetes, fertility, gastroenterology, infectious diseases (including HIV), oncology, osteoporosis, pain, respiratory, rheumatology, and transplantation.
Our core services include:
- Strategy development (market analyses, positioning work and communications strategy development)
- Strategic publications planning and execution
- Medical writing (supported by 40+ PhD qualified in-house medical writers)
- Opinion leader development
- Meetings inception and management
- Independent/promotional medical education
- Creative and branding
- Internal communications (including representative training materials).
As part of the Publicis Healthcare Communications Group, Medicus International is supported by the largest worldwide healthcare network, including Medicus and Discovery offices and the Saatchi & Saatchi Healthcare Group.
For further details contact
Peneli Oliver, Managing Director
peneli.oliver@medicusgroup.com
Jane Smith, Director of Client Services
jane.smith@medicusgroup.com
Or visit www.medicus-international.com
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
